Skip to content

Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment

A Study to Evaluate Patient and Physician Benefit/ Risk Preferences for Treatment of Metastatic Prostate Cancer (mPC) in Hong Kong: a Discrete Choice Experiment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05761093
Enrollment
306
Registered
2023-03-09
Start date
2022-09-07
Completion date
2026-03-31
Last updated
2025-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.

Interventions

None listed

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* aged 18 years or older, * diagnosis of metastatic prostate cancer within 5 years, * able to read and write, * accepting and signing the informed consent

Exclusion criteria

* if patients are unable to complete the survey by themselves due to physical or psychological reasons, * deemed ineligible by treating physicians if patients are unable to complete the survey by themselves due to physical or psychological reasons, * deemed ineligible by treating physicians

Design outcomes

Primary

MeasureTime frameDescription
Patient preferences for treatment attributes in prostate cancer from different stages of disease15 minutes (Once through survey)Derived from discrete choice experiment
The Preference weighting from Physicians involved in the treatment of prostate cancer in term of risk/benefit attributes of treatment.15 minutes (Once through survey)Derived from discrete choice experiment.

Secondary

MeasureTime frameDescription
To examine the effect of socio-economic status on preference weighing15 minutes (Once through survey)Derived from discrete choice experiment
To examine the status of comorbidities on preference weighing15 minutes (Once through survey)Derived from discrete choice experiment
To examine their willingness of trading off survival with improving QOL15 minutes (Once through surveyDerived from discrete choice experiment

Countries

Hong Kong

Contacts

Primary ContactChi Fai NG, MD
ngcf@surgery.cuhk.edu.hk35052625

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026